Nev.--(BUSINESS WIRE)--July 20, 2004-- Emergency Filtration
Products Inc. (OTCBB: EMFP) announced that it has
been notified that its application to apply for participation
in a Navy-funded Technology Transfer project (Center
of the Commercialization of Advanced Technology (CCAT))
commercialization and services which encompasses filter
technology products, has advanced to the final stages
of competition and evaluation. Accordingly, the company
will make a final technology presentation to a special
panel of subject matter experts on Monday, Aug. 9,
2004 in San Diego.
Assuming that EFP is selected to proceed following
the Aug. 9, 2004 presentation, the company will build
two filter product prototypes, both of which will
employ the company's patented 2H filter technology.
One of the prototypes will be built with the additional
protection offered by the company's proprietary nanotechnology
process in which the filter prototype will be treated
with a coating of nano particles.
The prototypes, which are expected to take approximately
one month to build, are designed for a large number
of potential applications, including, but not limited
to: biohazard masks, transportation (aircraft, tanks,
armored personnel carriers) and buildings (military,
industrial, office and residential).
The prototypes will then be tested over a period that
is expected to take one month or less. Assuming the
successful completion of prototype development and
testing, the filter products would then be produced
by a U.S. Navy-approved manufacturer.
The CCAT -- supported by Congress and funded by the
Department of Defense -- is a public-private collaborative
partnership between academia, industry, and government.
Partners include San Diego State University (SDSU)
Foundation and Entrepreneurial Management Center,
the University of California, San Diego (UCSD) Jacobs
School and UCSD CONNECT, and Lockheed Martin ORINCON
Technologies Inc. with support from the Space and
Naval Warfare Systems Center, San Diego. The consortium-style
CCAT intends to bridge the gap that exists between
the generators of technology, the Department of Defense
and the commercial marketplace. Web site: www.ccatsandiego.org
About Emergency Filtration Products Inc.
EFP is an air filtration products manufacturer whose
technology provides filtration efficiencies of "greater
than 99.99% at a particle size of 0.027 microns."
Its initial products were developed for the medical
market: the Vapor Isolation Valve(TM); RespAide --
a CPR mask used for resuscitation of respiratory/cardiac
arrest cases; an A.E.D. prep kit; and the 2H Breathing
Circuit Filter. Each has received FDA approval. EFP's
2H NanoMask with 27 nanometers filtration capability
relies on the company's core 2H Technology(TM) filtration
system, which utilizes a combination of hydrophobic
and hydrophilic filters able to capture and isolate
bacterial and viral microorganisms with efficiencies
of 99.99%. The environmental mask utilizes the company's
patented 2H Technology(TM) and nano-technology to
enhance the capture and isolation characteristics
of the filter media. In addition to filtration products,
the company also supplies Superstat, a modified hemostatic
collagen, to the medical market and U.S. military
for extreme wound care.
Emergency Filtration Products, Las Vegas